Arkolith/Insider Trading/AMRX/Form 4

Shah Nikita

Executive Vice PresidentAmneal Pharmaceuticals, Inc. (AMRX) · full profile →Form 4 · filed Mar 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
15
10 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)36K——418K
Mar 4, 2026Tax withholding(F)18K$13.30$239K400K
Mar 3, 2026Tax withholding(F)184K$13.31$2.4M382K
Mar 3, 2026Option exercise(M)367K——566K
Mar 3, 2026Tax withholding(F)12K$13.31$157K199K
Mar 3, 2026Option exercise(M)24K——211K
Mar 3, 2026Tax withholding(F)23K$13.31$306K187K
Mar 3, 2026Option exercise(M)46K——210K
Mar 3, 2026Tax withholding(F)19K$13.31$246K164K
Mar 3, 2026Option exercise(M)36K——183K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)36K—$072K
Mar 3, 2026Option exercise(M)367K—$00
Mar 3, 2026Option exercise(M)24K—$071K
Mar 3, 2026Option exercise(M)36K—$00
Mar 3, 2026Option exercise(M)46K—$046K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-015235) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML